ACI's 13th National Forum on Fraud and Abuse in the Sale and Marketing of Drugs
American Conference Institute’s 13th National Forum on Fraud and Abuse in the Sale and Marketing of Drugs: Reducing Legal Risks and Strengthening Compliance Efforts in the Face of Unprecedented Government Scrutiny at the ONE U.N. Hotel in New York
The government has made it clear that pharmaceutical companies are under a microscope, and the prosecutions will keep coming. Attend the leading conference which at which to gain the advanced strategies to bulletproof already-robust compliance plans and gain the competitive advantage.
In 2012, federal and state enforcement authorities have aggressively continued their pursuit of pharmaceutical companies for noncompliant sales and marketing practices, resulting in high profile investigations and record-breaking fines: $3 billion awarded against a major company stemming from unlawful promotion and kickbacks… $1.5 billion awarded against a company for unlawful promotion… $1.2 billion awarded against a company for unlawful promotion. In response to the challenges facing the pharmaceutical industry in this daunting climate, 13th National Forum on Fraud and Abuse in the Sale and Marketing of Drugs provides a forum for the key players - top federal and state prosecutors, preeminent corporate counsel, and leading counsel - to come together to give you a specific action plan to bolster your sales and marketing compliance regime and combat the next wave of fraud and abuse allegations.
Paul Hastings partner Palmina Fava is a featured speaker on Day Two to discuss "Comprehensive Fraud and Abuse T raining and Monitoring Action Plans to Minimize Risk When Sending Your Sales Team Into the Field" at 11:30 am. Discussion topics include:• Ensuring your company message is clear and successfully integrating compliance risk education into sales training from the start• Creating a real world training program for sales reps and marketers that goes beyond just legalese o Utilizing effective training techniques to test for knowledge retention o Continually updating training efforts to account for current investigations• Thinking like a sales rep: Understanding what drives successful relationships between your sales force and healthcare providers• Overseeing sales rep activity and conducting ride-alongs to understand the nature of the interactions between field force personnel and HCPs o Identifying communication strategies to help your reps stay on message when communicating with HCPs in known fraud and abuse liability problem areas including off-label marketing o Creating scenario specific training• Clearly establishing the consequences of non-compliance and setting forth the attendant sanctions and disciplinary actions
For additional information and to register, visit the ACI site